AKT1 and cancer: The compound’s ability to target and disrupt key molecular pathways involved in cancer progression, such as the PI3K/AKT/mTOR, NF-κB, STAT3, and MAPK signaling pathways, highlights its efficacy in suppressing cancer cell proliferation, promoting apoptosis, and inhibiting metastasis.